Enhertu® (fam-trastuzumab deruxtecan-nxki)
for Breast Cancer

Enhertu (fam-trastuzumab deruxtecan) is a targeted therapy and chemotherapy combination used to treat HER2-positive breast cancer, advanced stomach cancer, non-small cell lung cancer, and solid tumors with HER2 gene mutations. It is an antibody-drug conjugate (ADC) that targets HER2-positive cancer cells. Enhertu works by binding to HER2, slowing cancer growth, and delivering chemotherapy (deruxtecan) directly into the cells to destroy them.

Heart
Other top medicines used to treat Breast Cancer